Progress in the Synthesis of Analogues of Bistetrahdro-isoquinoline Antitumor Alkaloids

doi:10.6023/cjoc201810037

Chin. J. Org. Chem. ›› 2019, Vol. 39 ›› Issue (7): 1913-1922.DOI: 10.6023/cjoc201810037 Previous Articles Next Articles

Reviews

抗肿瘤活性双四氢异喹啉生物碱类似物的合成研究进展

杨扬^a, 郭举^a, 刘站柱^b

a 武汉工程大学绿色化工过程教育部重点实验室武汉 430205;
b 中国医学科学院/北京协和医学院药物研究所北京 100050

收稿日期:2018-10-30 修回日期:2019-01-25 发布日期:2019-03-29
通讯作者: 郭举, 刘站柱 E-mail:guoju1984@163.com;liuzhanzhu@imm.ac.cn
基金资助:
武汉工程大学科学研究基金（No.K201440）、湖北省教育厅科学研究计划指导性项目（No.B2016057）、新型反应器与绿色化学工艺湖北省重点实验室开放基金（No.201704）资助项目.

Progress in the Synthesis of Analogues of Bistetrahdro-isoquinoline Antitumor Alkaloids

Yang Yang^a, Guo Ju^a, Liu Zhanzhu^b

a Key Laboratory for Green Chemical Process of Ministry of Education, Wuhan Institute of Technology, Wuhan 430205;
b Institute of Materia Medica, China Academy of Medical Sciences & Peking Union Medical College, Beijing 100050

Received:2018-10-30 Revised:2019-01-25 Published:2019-03-29
Contact: 10.6023/cjoc201810037 E-mail:guoju1984@163.com;liuzhanzhu@imm.ac.cn
Supported by:
Project supported by the Research Fund Project of Wuhan Institute of Technology (No. K201440), the Pilot Program of Scientific Research Project of Hubei Provincial Department of Education (No. B2016057), the Open Fund of Key Laboratory of New Reactor and Green Chemical Technology of Hubei Provincial (No. 201704).

Since the first tetrahydroisoquinoline alkaloid (THIQ), naphthyridinomycin, was found by Canadian scientist Kluepfel in 1974, nearly hundred members of this family have been reported. Such THIQ has attracted the research interest of many chemists and biologists due to its excellent biological activity and complex chemical structure. Especially, as an outstanding member of THIQ family, Ecteinascidin 743 (ET-743) has been commercialized in the European Union for the treatment of soft tissue tumors and ovarian cancer. Due to the extremely low content of natural products of bistetrahydroisoquinoline including ET-743 and the complexity of its chemical structure, the modification of its chemical structure has attracted more and more attention. Based on this, the recent advance in the synthesis of bistetrahydroisoquinoline analogues is reviewed.

Key words: antitumor activity, bistetrahydroisoquinoline alkaloid, analogue, research progress

Cite this article

Yang Yang, Guo Ju, Liu Zhanzhu. Progress in the Synthesis of Analogues of Bistetrahdro-isoquinoline Antitumor Alkaloids[J]. Chin. J. Org. Chem., 2019, 39(7): 1913-1922.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Kluepfel, D.; Baker, H. A.; Piattoni, G.; Sehgal, S. N.; Sidorowicz, A.; Singh, K.; Vezina, C. J. Antibiot. 1975, 28, 497.
[2] Scott, J. D.; Williams, R. M. Chem. Rev. 2002, 102, 1669.
[3] Martinez, E. J.; Owa, T.; Schreiber, S. L.; Corey, E. J. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 3496.
[4] Martinez, E. J.; Corey, E. J.; Owa, T. Chem. Biol. 2001, 8, 1151.
[5] Plowright, A. T.; Schaus, S. E.; Myers, A. G. Chem. Biol. 2002, 9, 607.
[6] Cuevas, C.; Manzanares, I.; Perez, M.; Martin, M. J.; Rodriguez, A.; Munt, S. (Pharma Mar, S. A.). ES 2231486 T3, 2003.
[7] Corey, E. J.; Gin, D. Y.; Kania, R. S. J. Am. Chem. Soc. 1996, 118, 9202.
[8] Eduardo, J. M.; Corey, E. J. Org. Lett. 1999, 1, 75.
[9] Cuevas, C.; Pérez, M.; Martín, M. J.; Chicharro, J. L.; Fernádez, R. C.; Flores, M.; Francesch, A.; Gallego, P.; Zarzuelo, M.; Calle, F.; García, J.; Polanco, C.; Rodríguez, I.; Manzanares, I. Org. Lett. 2000, 2, 2545.
[10] Chen, J.-C.; Chen, X.-C.; Michele, B. C.; Zhu, J.-P. J. Am. Chem. Soc. 2006, 128, 87
[11] Chen, X.; Zhu, J. Angew. Chem., Int. Ed. 2007, 46, 3962.
[12] Jonathan, W.; Chen, Y.-Y.; Williams, R. M. J. Am. Chem. Soc. 2005, 127, 12684.
[13] Smith, L. H. S.; Nguyen, T. T.; Sneddon, H. F.; Procter, D. J. Chem. Commun. 2011, 47, 10821
[14] Xu, S.-H.; Wang, G.; Zhu, J.-J.; Shen, C.; Yang, Z.-Z.; Yu, J.; Li, Z.; Lin, T.-H.; Sun, X.; Zhang, F.-L. Eur. J. Org. Chem. 2017, 5, 975.
[15] Wang. Y.; Tang, Y.-F.; Liu, Z.-Z.; Chern, S.-Z.; Liang, X.-T. Chin. J. Org. Chem. 2005, 25, 42(in Chinese). (王晔, 唐叶峰, 刘站柱, 陈世智, 梁晓天, 有机化学, 2005, 25, 42.)
[16] Liao, X,-W.; Dong, W.-F.; Liu, W.; Chen, S.-Z.; Liu, Z.-Z. Chin. J. Org. Chem. 2010, 30, 317(in Chinese). (廖祥伟, 董文芳, 刘伟, 陈世智, 刘站柱, 有机化学, 2010, 30, 317.)
[17] Song, Y.-T.; Hu, L.-L.; Chen, R.-J.; Chen, X.-C. Chin. J. Org. Chem. 2015, 35, 1627(in Chinese). (宋玉廷, 胡玲玲, 陈瑞蛟, 陈小川, 有机化学, 2015, 35, 1627.)
[18] Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Kieffer, P. A.; Sun, F.; Li, L.-H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512.
[19] Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Kieffer, P. A.; Sun, F.; Li, L.-H.; Martin, D. G. J. Org. Chem. 1991, 56, 1676.
[20] Endo, A.; Yanagisawa, A.; Abe, M.; Tohma, S.; Kan, T.; Fukuyama, T. J. Am. Chem. Soc. 2002, 124, 6552.
[21] Zheng, S.; Chan, C.; Furuuchi, T.; Wright, B.; Zhou, B.; Guo. J.; Danishefsky, S. J. J. Angew. Chem., Int. Ed. 2006, 45, 1754.
[22] Jeffrey, R..; Martin, S.; Jason, O.; Peter, S.; Stacie, A. D.; Catherine, M.; Hyunjin, M. K.; Zhang, P-L.; Neil, S.; Katherine, G. M.; Juthamas, S.; Doris, G.; Ohn, E.; Peter, R. Y.; Myers, A. G.; Green, M. J. Bioorg. Med. Chem. Lett. 2006, 16, 4884.
[23] Ocio, E. M.; Maiso, P.; Chen, X.; Garayoa, M.; Alvarez-Fernandez, S.; SanSegundo, L.; Vilanova, D.; Lopez-Corral, L.; Montero, J. C.; HernandezIglesias, T.; Alava, E.; Galmarini, C.; Aviles, P.; Cuevas, C.; Pandiella, A. Blood. 2009, 113, 3781.
[24] Leal, J. F. M.; Garcia-Hernandez, V.; Moneo, V.; Domingo, A.; Bueren-Calabuig, J. A.; Negri, A.; Gago, F.; Guillen-Navarro, M. J.; Aviles, P.; Cuevas, C.; GarciaFernandez, L. F.; Galmarini, C. Biochem. Pharmacol. 2009, 78, 162.
[25] Roberto, M.; Martinez, V.; Alberto, R.; Natividad, R.; Flores, M.; Gallego, P.; Manzanares, I.; Cuevas, C. J. Org. Chem. 2003, 68, 8859.
[26] Plácido, A. C.; Marta, P.; Cuevas, C.; Andrés, F.; Manzanares, I.; Antonio, M.; Echavarren. Eur. J. Org. Chem. 2006, 8, 1926.
[27] Zhou, B.-S.; Guo, J. S.; Danishefsky, S. J. Tetra. Lett. 2000, 41, 2043.
[28] Benjamin, J.; Wright, D.; Collin C.; Danishefsky, S. J. J. Nat. Prod. 2008, 71, 409.
[29] Kubo, A.; Saito, N.; Yamauchi, R.; Sakai, S. Chem. Pharm. Bull. 1987, 35, 2158.
[30] Kubo, A.; Saito, N.; Yamato, H.; Kawakarmi, Y. Chem. Pharm. Bull. 1987, 35, 2525.
[31] Kubo, A.; Saito, N.; Nakamura, M.; Ogata, K.; Sakai, S. Heterocycles 1987, 26, 1765.
[32] Kubo, A.; Saito, N.; Yamato, H.; Yamauchi, R.; Hiruma, K.; Inoue, S. Chem. Pharm. Bull. 1988, 36, 2607.
[33] Kubo, A.; Saito, N.; Yamato, H.; Masubuchi, K.; Nakamura, M. J. Org. Chem. 1988, 53, 4295.
[34] Shinya, K.; Shintaro, K.; Masayuki, A.; Yoshifumi, U.; Koizumi, Y.; Masashi, Y.; Saito, N. Heterocycles 2015, 90, 327.
[35] Masashi, Y.; Ryoko, T.; Toshihiro, S.; Vy, H. L.; Williams, R. M.; Saito, N. J. Org. Chem. 2016, 81, 4039.
[36] Christian, R.; Razafindrabe.; Sylvain, A.; Benjamin B.; Andriantsiferana, M.; Stéphane, P. R.; Lemaire, M. Tetrahedron 2010, 66, 9061.
[37] Kawagishi, F.; Toma, T.; Inui, T.; Yokoshima, S.; Fukuyama, T. J. Am. Chem. Soc. 2013, 135, 13684.
[38] Chen, R.; Liu, H.; Chen, X. J. Nat. Prod. 2013, 76, 1789.
[39] Chen, R.; Zhu, D.; Hu, Z.; Zheng, Z.; Chen, X. Tetrahedron:Asymmetry 2010, 21, 39.
[40] Chen, R.; Liu, H.; Liu, X.; Chen, X. Tetrahedron 2013, 69, 3565.
[41] Liu, H.; Chen, R.; Chen, X. Org. Biomol. Chem. 2014, 12, 1633.
[42] Jia, J.; Chen, R.; Liu, H.; Li, X.; Jia, Y.; Chen, X. Org. Biomol. Chem. 2016, 14, 7334.
[43] González, J. F.; Cuesta, E.; Avendano, C. Bioorg. Med. Chem. 2007, 15, 112.
[44] Ortín, I.; González, J. F.; Cuesta, E.; Cristina, M. G.; Rosario P.; Avendano, C. Bioorg. Med. Chem. 2008, 16, 9065.
[45] Ortín, I.; González, J. F.; Cuesta, E.; Avendano, C. Tetrahedron 2009, 65, 2201.
[46] Ortín, I.; González, J. F.; Cuesta, E.; Avendano, C. Tetrahedron 2009, 65, 9944.
[47] Ortín, I.; González, J. F.; Cuesta, E.; Avendano, C. Bioorg. Med. Chem. 2010, 18, 6813.
[48] Tuyen, N. V.; Pieter, C.; Norbert, D. K. Synlett 2014, 45, 69.
[49] Tang, Y.-F.; Liu, Z.-Z.; Chen, S.-Z. Tetrahedron Lett. 2003, 44, 7091.
[50] Liao, X.-W.; Liu, W.; Dong, W.-F.; Guan, B.-H.; Chen, S.-Z.; Liu, Z.-Z. Tetrahedron 2009, 65, 5709.
[51] Liu, W.; Dong, W.-F.; Liao, X.-W.; Yan, Z.; Guan, B.-H.; Wang, N.; Liu, Z.-Z. Bioorg. Med. Chem. Lett. 2011, 21, 1419.
[52] Dong, W.-F.; Liu, W.; Liao, X.-W.; Guan, B.-H.; Chen, S.-Z.; Liu, Z.-Z. J. Org. Chem. 2011, 76, 5363.
[53] Liu, W.; Liao, X.-W.; Dong, W.-F.; Yan, Z.; Wang, N.; Liu, Z.-Z. Tetrahedron 2012, 68, 2759.
[54] Dong, W.-F.; Liu. W.; Yan, Z.; Liao, X.-W.; Guan, B.-H.; Wang, N.; Liu, Z.-Z. Eur. J. Med. Chem. 2012, 49, 239.
[55] Liu, Z.-Z.; Wang, Y.; Tang, Y.-F.; Chen, S.-Z.; Chen, X.-G.; Li, H.-Y. Bioorg. Med. Chem. Lett. 2006, 16, 1282.
[56] Guo, J.; Dong, W.-F.; Liu, W.; Yan, Z.; Wang, N.; Liu, Z.-Z. Eur. J. Med. Chem. 2013, 62, 670.
[57] Guo, J.; Yang, Y.; Wang, N.; Liu, Z.-Z. Tetrahedron Lett. 2018, 33, 3202.
[58] Lu, X.-R.; Pan, X.; Yang, Y.; Ji, M.; Chen, X.-G.; Xiao, Z.-Y.; Liu, Z.-Z. Eur. J. Med. Chem. 2017, 135, 260.
[59] Eric, R. W.; Aurapat, N.; Max, K.; Guillaume, L.; Gerit, M. P.; Martina, S. J. M.; Dylan, C.; Christopher, D. G.; Pamela, M. T.; Christopher, K. H.; Kenji, N.; Emil, G.; Christian, U. G.; Kevin, M. A.; Scott, C. V.; Dennis, J. S.; Brian, M. S. Science 2019, 363, 270.

抗肿瘤活性双四氢异喹啉生物碱类似物的合成研究进展

Progress in the Synthesis of Analogues of Bistetrahdro-isoquinoline Antitumor Alkaloids

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xiaoying Jia, Jiaxia Pu, Lirong Han, Qinghan Li. Research Progress in the Synthesis of Benzo[d]pentamembered Heterocyclic Thioethers Containing Two Heteroatoms [J]. Chinese Journal of Organic Chemistry, 2024, 44(1): 18-40.
[2]	Zhiyou Huang, Ping Yang, Bo He, Wenxia Ou, Siyu Yuan. Design and Synthesis of Morpholine Sulfonamide Compound and Its Inhibition on Soybean Seed Germination [J]. Chinese Journal of Organic Chemistry, 2024, 44(1): 309-315.
[3]	Bozhen Wang, Jie Zhang, Chunhui Nian, Mingming Jin, Miaomiao Kong, Wulan Li, Wenfei He, Jianzhang Wu. Synthesis and Antitumor Activity of 3,4-Dichlorophenyl Amides [J]. Chinese Journal of Organic Chemistry, 2024, 44(1): 232-241.
[4]	Jiaxia Pu, Xiaoying Jia, Lirong Han, Qinghan Li. Research Progress of Visible Light Promoted C—N Bond Fracture to Construct C—C Bond [J]. Chinese Journal of Organic Chemistry, 2023, 43(8): 2591-2613.
[5]	Panxing Pang, Rong Ning, Chuang Zhu, Wenjie Huang, Xianli Ma, Caina Jiang, Fangyao Li, Xiaoqun Zhou. Synthesis and in Vitro Antitumor Activity of Matrine Semicarbazide Derivatives [J]. Chinese Journal of Organic Chemistry, 2023, 43(6): 2126-2135.
[6]	Kanghui Duan, Junlong Tang, Wanqing Wu. Recent Advances in the Synthesis of Fused Heterocyclic Compounds and Their Antitumor Activities [J]. Chinese Journal of Organic Chemistry, 2023, 43(3): 826-854.
[7]	Zujia Lu, Jian Qin, Jinting Wu, Wenli Cao, Baolong Kuang, Jianguo Zhang. Advances in the Synthesis of Energetic Compounds Based on 1,2,3-Triazoles [J]. Chinese Journal of Organic Chemistry, 2023, 43(2): 526-554.
[8]	Peng Liu, Fuming Zhong, Lihao Liao, Weiqiang Tan, Xiaodan Zhao. Progress in the Construction of Spirocyclohexadienones via Alkyne-Involving Dearomatization [J]. Chinese Journal of Organic Chemistry, 2023, 43(12): 4019-4035.
[9]	Weiqin Liu, Lihui Shao, Chengpeng Li, Yayu Zou, Haitao Long, Yan Li, Qiangsheng Ge, Zhenchao Wang, Guiping Ouyang. Synthesis and Antitumor Activity of 3-Hydrazone Quinazolinone Derivatives [J]. Chinese Journal of Organic Chemistry, 2023, 43(1): 214-222.
[10]	Dongyan Hu, Guangtian Han, Xi'an Li, Huazhong Ren, Lirong Yue, Li Guo, Jiafu Feng. Synthesis and Evaluation in vitro of Novel Harmine Derivatives as Anticancer Activity Agents [J]. Chinese Journal of Organic Chemistry, 2022, 42(6): 1863-1871.
[11]	Can Yong, Yun Li, Tao Bi, Guofeng Chen, Dongxia Zheng, Zhouyu Wang, Yuanyuan Zhang. Research Progress on the Synthesis and Activity of D-Galactose Derived Small Galectin Inhibitors [J]. Chinese Journal of Organic Chemistry, 2022, 42(5): 1307-1325.
[12]	Zhihao Zhang, Xin Jiang, Qinghan Li. Recent Progress in the Synthesis of Substituted Benzo[b]furan Derivatives [J]. Chinese Journal of Organic Chemistry, 2022, 42(4): 945-964.
[13]	Lu Xue, Lihua Zhang, Chengyu Zhang, Xin Zhao, Weifan Dang, Zhaoxin Wang, Chunhua Wang, Tongchuan Suo, Xiaohui Yan. Discovery of Tiancimycin Congeners from Streptomyces sp. CB03234-S [J]. Chinese Journal of Organic Chemistry, 2022, 42(4): 1241-1247.
[14]	Honglin Dai, Xiaojie Si, Lingling Chi, Hao Wang, Chao Gao, Zhengjie Wang, Limin Liu, Jiajie Ma, Fuqiang Yu, Hongmin Liu, Yu Ke, Qiurong Zhang. Synthesis and Antitumor Activity Evaluation of 2,4,6-Trisubstituted Quinazoline Derivatives Containing Thiazole Structure [J]. Chinese Journal of Organic Chemistry, 2022, 42(11): 3853-3862.
[15]	Lijun Yin, Chaoqun Li, Xiaoxia Wu, Guangsen Xu, Zhiying Li, Yuemao Shen. Synthesis of (E)-N-(4-Styrene) Acrylamides for DNA Topoisomerase IIα Inhibitors and Antitumor Agents [J]. Chinese Journal of Organic Chemistry, 2022, 42(1): 293-301.